Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
25
NCT05135312
Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging
Phase: Phase 4
Role: Lead Sponsor
Start: Aug 9, 2021
Completion: Aug 8, 2022
NCT05265234
Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.
Start: Mar 1, 2022
Completion: Mar 1, 2024